CMH Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,949
| Closed | -$3.08M | – | 59 |
|
|
2025
Q1 | $3.08M | Sell |
37,949
-186
| -0.5% | -$15.1K | 0.77% | 41 |
|
|
2024
Q4 | $3.43M | Sell |
38,135
-26,294
| -41% | -$2.37M | 0.79% | 42 |
|
|
2024
Q3 | $6.37M | Sell |
64,429
-1,424
| -2% | -$141K | 1.5% | 33 |
|
|
2024
Q2 | $6.11M | Buy |
65,853
+295
| +0.4% | +$27.3K | 1.5% | 34 |
|
|
2024
Q1 | $6.22M | Sell |
65,558
-8,278
| -11% | -$785K | 1.58% | 32 |
|
|
2023
Q4 | $6.59M | Buy |
73,836
+2,797
| +4% | +$250K | 1.6% | 28 |
|
|
2023
Q3 | $5.19M | Buy |
71,039
+8,812
| +14% | +$643K | 1.45% | 32 |
|
|
2023
Q2 | $5.18M | Buy |
62,227
+1,240
| +2% | +$103K | 1.39% | 32 |
|
|
2023
Q1 | $4.65M | Buy |
60,987
+1,335
| +2% | +$102K | 1.34% | 33 |
|
|
2022
Q4 | $4.95M | Sell |
59,652
-34
| -0.1% | -$2.82K | 1.59% | 30 |
|
|
2022
Q3 | $4.73M | Sell |
59,686
-489
| -0.8% | -$38.8K | 1.74% | 22 |
|
|
2022
Q2 | $4.47M | Sell |
60,175
-19,419
| -24% | -$1.44M | 1.62% | 20 |
|
|
2022
Q1 | $7.15M | Buy |
79,594
+13,593
| +21% | +$1.22M | 2.2% | 12 |
|
|
2021
Q4 | $7.39M | Sell |
66,001
-200
| -0.3% | -$22.4K | 2.23% | 15 |
|
|
2021
Q3 | $8.32M | Buy |
66,201
+3,044
| +5% | +$383K | 2.73% | 10 |
|
|
2021
Q2 | $8.55M | Buy |
63,157
+4,130
| +7% | +$559K | 2.86% | 10 |
|
|
2021
Q1 | $8.01M | Buy |
59,027
+201
| +0.3% | +$27.3K | 3.02% | 8 |
|
|
2020
Q4 | $8.28M | Sell |
58,826
-2,090
| -3% | -$294K | 3.03% | 10 |
|
|
2020
Q3 | $6.79M | Buy |
60,916
+3,075
| +5% | +$343K | 2.9% | 8 |
|
|
2020
Q2 | $6.48M | Buy |
57,841
+12,293
| +27% | +$1.38M | 3.09% | 8 |
|
|
2020
Q1 | $3.53M | Buy |
+45,548
| New | +$3.53M | 2.06% | 18 |
|